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Abstract 
Objective: The purpose of this study is to determine the effectiveness of individualized communication strategies and self-management 
action plans to improve A1c control at 3 months in patients with low health literacy.  
Methods: A prospective, open-labeled, pilot study was conducted on 23 patients with diabetes mellitus in a pharmacist-led ambulatory 
care clinic. Patients who had a Rapid Estimate of Adult Literacy in Medicine- Revised (REALM-R) score of 6 or less and an A1c greater 
than 7% upon study entry were included. The first group received the teach-back method, personalized actions, and follow-up phone 
calls to assess comprehension (N = 12). The second group was assigned to usual care (N = 11). 
Results: Patients receiving literacy-appropriate interventions had greater A1c percent reduction (A1c difference of -2.0 ± 1.3 vs -1.0 ± 
2.2; P = 0.02) and less hyperglycemic events per week (0.1 vs. 2.1; P = 0.04). There were no differences in the number of hypoglycemic 
events, testing frequency, medication-adherence rates, or hospitalizations and emergency room visits related to diabetes.  
Conclusion: Literacy-appropriate methods such as the teach-back method, personalized action plans, and telephone follow-ups may 
improve glycemic control in low health literate patients with diabetes.  
Practice Implications and Innovations: The findings from this study suggest that pharmacists may improve diabetes outcomes when 
managing patients who possess low health literacy using simplified teaching methods. 
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Introduction 
Diabetes is a chronic disease that currently affects 30.3 million 
Americans and has resulted in substantial morbidity, mortality, 
and financial burden.1 Among these, it is estimated that 15-40% 
of all patients with diabetes possess low health literacy.2 Health 
literacy is defined as the “degree in which individuals have the 
capacity to obtain, process, and understand basic health 
information and services needed to make appropriate health 
decisions”.3 Health numeracy is a component of health literacy 
and involves the understanding of numbers in disease state 
management. Daily diabetes activities rely on having adequate 
numeracy skills to carry out self-care tasks including 
carbohydrate counting, insulin titration, and blood glucose 
monitoring. Many aspects of diabetes care require adequate 
health literacy including lifestyle management, appropriate 
medication usage, self-testing procedures, and self-
management of hyperglycemia and hypoglycemia. Studies 
show that patients with poor health literacy have worse clinical  
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outcomes. 4 For every one-point decrease in the Short Test of 
Functional Health Literacy Assessment (s-TOFHLA) score, a 
0.02% rise in the A1c was observed. Patients with diabetes who 
have limited health literacy also have poorer disease state 
knowledge, lower self-confidence in diabetes management, 
and difficulty understanding and adhering to medication 
instruction.5  
 
While there is consensus in the definitions for health literacy 
and standardized health literacy measurement instruments, 
gaps in the literature currently remain on the association of 
health literacy to health outcomes in patients with diabetes. 
Empiric research contains contradictory results about the 
association of health literacy to self-care, adherence, and 
glycemic control.6,7 Additionally, it is unclear how health literacy 
is associated with self-efficacy, which is the relationship 
between knowledge and behavior, and how health 
professionals’ communication strategies can impact patient 
understanding.6,7 Sayah et al.8 revealed that only 11% of all 
communication loops in a diabetes primary care center were 
closed where health information was either clarified, repeated, 
or checked for understanding. Medical jargon and mismatched 
language were used often in encounters in patients with low 
health literacy.8 Finally, the cost-effectiveness of interventions 
that improve health literacy are unknown. Limited health 
literacy in patients with type 2 diabetes adds an additional 3-
5% to total healthcare costs in the United States every year.7 
Best practices which are simplistic to carry out in a primary care 
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setting for patients with diabetes so that these patients may 
improve their glycemic control, frequency of testing, and 
medication adherence to ultimately drive down healthcare 
costs is largely needed. This study aims to explore the 
relationship between low health literacy and diabetes 
outcomes using cost-effective interventions by pharmacy 
professionals. 
 
The use of the teach-back method and personalized action 
plans are simple, cost-effective techniques that have been 
shown to be successful in changing health behavior.9 The teach-
back method is a framework for assessing and enhancing 
patient understanding by closing the communication loop. By 
allowing patients to explain in their own words medical 
information, the teach-back method improves patient-provider 
communication, promotes medication adherence, and 
increases patient safety.9 Personalized action plans revolve 
around the socio-behavioral model of care where patients have 
an active voice in the decision-making process.9 In this patient-
centered approach, the patient can negotiate their behavior 
during the information exchange to allow for realistic, 
successful treatment regimens.9 Both methods allow the 
patient to be actively engaged in their own care and 
accountable for their own health. Few studies thus far have 
assessed the impact of a pharmacist-driven program using 
these combined methods to improve glycemic control in 
patients with low health literacy. 
 
The purpose of this study is to determine the effectiveness of 
individualized communication strategies and self-management 
action plans to improve A1c control at 3 months in patients with 
low health literacy. We hypothesize that patients who receive 
targeted counseling sessions and individualized goal-setting 
plans will have achieved better glycemic control compared to 
those who receive standard of care. 
 
Research Design 
A prospective, open-labeled, pilot study was conducted in 
Medicine Group Practice (MGP) clinic patients at a tertiary-care, 
teaching hospital. Patients were seen for scheduled study visits 
at one to four week intervals over a planned period of 3 
months. An institutional review board at the site approved the 
protocol, and patients provided written informed consent.  
 
Patients were eligible to participate if they were at least 18 
years of age with a diagnosis of type 1 or type 2 diabetes and 
possessed low health literacy, defined as a Rapid Estimate of 
Adult Literacy in Medicine- Revised (REALM-R) score of 6 or less. 
The REALM-R is a validated health literacy instrument used to 
assess a person’s ability to read and pronounce 11 common 
medical words.10 The test assesses how well patients read 
words that are common to the primary care setting and are 
expected to understand when interacting with their provider. 
While there are many standardized health literacy tests 
available (e.g. s-TOFHLA, Newest Vital Sign [NVS]), the REALM-
R was chosen for this study due to its rapid administration and 
ease of scoring. Research has shown that scores of 6 or less out 
of a total of 8 points identify patients at risk for low health 
literacy.10 In addition, patients also needed to have an A1c 
greater than 7% upon study entry. Patients with a diagnosis of 
stroke in the past 3 months, dementia, Alzheimer’s disease, 
receiving pharmacotherapy for Alzheimer’s or dementia, such 
as acetylcholinesterase inhibitors or memantine, were 
excluded. In addition, non-English speakers, patients with visual 
impairment, and patients without access to a telephone were 
not eligible for this study. 
 
Methodology 
All eligible patient underwent block randomization into the 
interventional or usual care arm. Both groups met with 
pharmacists in a collaborative-practice run clinic for medication 
management and diabetes education. During enrollment, the 
REALM-R and Diabetic Numeracy Test-5 (DNT-5) was 
administered to all subjects.  The DNT-5 is a standardized 
assessment test consisting of mathematical calculations and 
real-world applications to determine numeracy skills in patients 
with diabetes.6 This abbreviated five-question DNT-5 was also 
chosen for its quick administration and scoring over the original 
test, the 43-question Diabetic Numeracy Test (DNT). Subjects 
who score 3 or less on this test out of a total 5 points are more 
likely to possess low numeracy skills. Both instruments are 
available on the public domain. 
 
Patients in the interventional arm received the teach-back 
method and action plans at every clinic visit to re-assess their 
knowledge (Table 1). The teach-back method involved asking 
the patient to explain or demonstrate what they have been told 
in order to confirm understanding. An action plan consisting of 
one to three goals was also created for diabetes management 
at the end of the visit. Action plans were created through a 
shared decision making approach between the provider and 
patient working collaboratively to allow for patient 
empowerment. The patient rated their confidence of achieving 
the action plan on a Likert scale of 1 (not sure) to 10 (very sure). 
Action plans with a score of 6 or less were modified so that the 
patient was more comfortable with completing the goal.9 
 
In addition, follow-up phone calls were conducted every 2-4 
weeks at the halfway point in-between visits to assess 
comprehension and for further education reinforcement. The 
teach-back method was also performed during these phone 
sessions, and action plans were also allowed to be modified if 
the score was 6 or less. Patients in the control arm received 
usual care only, without the use of the teach-back method, 
action plans, or any telephone follow-ups. In this practitioner-
centered model, even though information was given during 
appointments, patients were not assessed for their 
understanding through the teach-back method to close the 
communication loop, and treatment decisions were made 
solely by the pharmacist without assessing the patient’s 
confidence level to carry out the plan. 
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A pharmacist with specialized knowledge and training in 
diabetes carried out all protocol procedures including 
education, medication titration, data recording, and 
monitoring. The same pharmacist personnel interacted with all 
study participants to ensure continuity and reliability. Both 
groups were managed under the clinic’s collaborative practice 
agreement treatment protocol for diabetes, and standardized 
insulin titration procedures including Treat-to-Target and the 
rule of 1800 were used to adjust insulin dosages.11,12 The 
Pharmacist’s Patient Care Process was followed through the 
collaborative practice agreement to deliver evidence-based 
care to all participants through data collection, assessment, 
planning, implementation, and evaluation.13 
 
At every study visit, blood glucose values were obtained by the 
pharmacist using a point-of-care glucometer. The frequency of 
hypoglycemia or hyperglycemia and frequency of testing were 
screened every encounter by patient-reported questionnaires 
and through the patient’s self-monitoring blood glucose 
(SMBG) logs. In addition, hospitalization and emergency room 
visits related to diabetes were measured by patient report and 
confirmed with medical records. Total adherence rate for the 
study duration was verified by pharmacy refill records through 
the software program PrescribeWellness. A1c samples were 
taken by laboratory venous blood tests at baseline and upon 
study termination as per standard of care practice guidelines. 
 
Study Endpoints 
The primary endpoint was the mean change in A1c value at 3 
months. This value was represented in one of two ways; either 
as the difference between the initial and final A1c, or shown as 
a percent reduction by the above value divided by the initial A1c 
multiplied by 100 percent. For example, if a subject has a 
baseline A1c of 8% (183 mg/dL, 10.2 mmol/L) upon study entry 
and the A1c decreases to 7.1% (157 mg/dL, 8.7 mmol/L) at the 
3 month period, then the difference in A1c is -0.9% and the 
percent reduction is -11.25%.   
 
Secondary endpoints included the number of blood glucose 
values obtained during clinical visits that were less than 70 
mg/dL (3.88 mmol/L) or greater than 180 mg/dL (9.99 mmol/L). 
The number of patients reaching an A1c of less than 7% and the 
change in frequency of glucose testing from baseline were 
assessed. The frequency of hypoglycemia, defined as a glucose 
level less than 70mg/dL (3.88 mmol/L) or symptoms of low 
blood sugar such as dizziness, sweating, shaking or trembling, 
or hyperglycemia, defined as a glucose level of greater than 
300mg/dL (16.65 mmol/L) or symptoms of high blood sugar 
such as extreme thirst, frequent urination, drinking or eating 
episodes, were also recorded. Other secondary endpoints 
include the number of hospitalizations or emergency room 
visits for diabetes-related complications and medication 
adherence rates over the course of 3 months. 
 
 
 
Statistical Analysis 
A total of 40 patients were needed to obtain a statistical power 
of 80 percent to detect a 1% difference in A1c values between 
the two treatment arms. However, to account for drop-outs, a 
goal of 50 patients for recruitment was selected. All P-values 
were 2-sided and P-values ≤ 0.05 were considered statistically 
significant. Continuous variables were presented as means with 
standard deviations, and P-values for continuous categorical 
data were computed with the use of a nonparametric Wilcoxon 
test. Fisher’s Exact Test was used for dichotomous categorical 
data. Treatment comparisons were performed with the use of 
a per-protocol analysis. Data was analyzed using SPSS® and 
Minitab®. 
 
Results 
A total of 25 patients underwent randomization during the 3 
month enrollment phase (Figure 1). Of these, 13 patients were 
assigned to receive health-literacy appropriate interventions 
and 12 patients were assigned to receive usual care. At the end 
of the study period, 2 patients (15.38%) were lost to follow-up 
in the interventional arm, leaving a total of 11 patients in the 
treatment arm and 12 patients in the usual care arm to be 
included in the primary analysis. Baseline demographics are 
shown in Table 2. The study sample was comprised of a middle-
aged population that was predominantly women (60.87%) and 
African-American (91.30%). The majority of patients possessed 
a high-school education (56.52%) or lower and had type 2 
diabetes (95.65%). The two groups were well matched for 
baseline characteristics except for duration of diabetes (P = 
0.01). In regards to the type of diabetes regimen (Table 3), the 
majority of patients were on an insulin-oral combination and 
the usual care arm had a higher total usage of insulin per 
kilogram of body weight compared to intervention arm (0.96 ± 
0.78 vs. 0.41 ± 0.35, respectively, P = 0.05). Scores of 6 or 
less on the REALM-R and 3 or less on the DNT-5 indicate low 
literacy and numeracy. The average REALM-R score of 2 and 4.1 
in usual care and intervention, respectively, as well as a mean 
DNT-5 score of 1.3 in both arms reveals a population that had 
both poor health literacy and numeracy. There were also no 
differences in baseline A1c in both treatment arms (9.3% in 
usual care arm vs. 9.7% in interventional arm, P = 0.47). Patients 
in the interventional arm created an average of two action 
plans per visit. 
 
At the end of three months, most patients were still on an 
insulin-oral regimen and there were more patients on an 
insulin-only regimen in the usual care arm (P = 0.04). There 
were no differences in the total units of insulin per kilogram of 
body weight between the two arms at the end of the study 
(0.84 ± 0.53 vs. 0.48 ± 0.31, P = 0.12). While average A1c value 
at study termination was comparable between the groups 
(Figure 2), the treatment arm achieved a greater reduction in 
the primary endpoint (Table 4). The A1c difference was a mean 
reduction of only 1% in the usual care arm compared to a 2% 
reduction in the treatment arm (P = 0.02). The intervention 
team also had a greater mean A1c percent reduction of 20.3% 
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versus a 9.1% decrease in the usual care arm (P = 0.04). There 
were no differences in the number of patients who reached a 
A1c of less than 7% (154 mg/dL, 8.7 mmol/L) or the number of 
blood glucose values in clinic that were less than 70mg/dL (3.88 
mmol/L) or greater than 180 mg/dL(9.99 mmol/L). While there 
was no difference between the number of hypoglycemic 
events, patients in the treatment arm experienced less 
hyperglycemic events per week (0.1 vs. 2.1; P = 0.04). Finally, 
there were no statistical differences between the number of 
hospitalizations or emergency room visits related to diabetes, 
testing frequency, and medication adherence rates. 
 
Discussion 
Many misconceptions may arise in patients with low literacy 
when controlling and managing their diabetes which lead to 
complications. In a study where participants had below a 6th 
grade reading level with an A1c of greater than 8% (183 mg/dL, 
10.2 mmol/L), 61% believed they were managing their diabetes 
well and correspondingly did not see their physician.14 Patients 
who believe that they have firm control of their diabetes are 
less likely to seek medical assistance and make changes in their 
regimen. Additionally, a study conducted by Fan et al.15 showed 
low-income, African-Americans with low health literacy and an 
education level of high school or less had higher rates of 
medication non-adherence. The patient demographics in Fan et 
al.15 were similar to the participants in the GLITTER-DM study 
with equal rates of non-adherence. Patients with diabetes who 
possess low health literacy may have trouble following 
prescription medication instructions including indication, 
dosage, frequency of administration, and special instructions.16 
There is also an association where patients with diabetes who 
have lower literacy levels will have worse communication 
quality, higher levels of mistrust, and less engagement with 
medical providers.17,18 Not only does this impact their medical 
care, but this population has worse self-care routines including 
lower rates of physical fitness and healthy eating habits.18 
Similarly, patients in the GLITTER-DM study assigned to usual 
care had difficulty understanding medical information, 
performing self-care behaviors, and maintaining glycemic 
control.  The complexities of literacy affect all aspects of a 
patient’s disease-state management and have the potential for 
serious consequences. 
 
The results of this pilot study suggests that closing the 
communication loop by using simple literacy-appropriate 
intervention strategies, such as the teach-back method and 
action plans, as well as telephone follow-up calls to reinforce 
patient understanding are effective methods of improving 
diabetes control. Similarly, Wallace et al.19 also performed 
these interventions in a sample where 28.8% of the subjects 
had inadequate health literacy and found improvements in self-
efficacy, diabetes-related distress, and knowledge (P < 0.001). 
Another study by Rothman et al.20 showed that the teach-back 
method and simplified medical jargon resulted in A1c 
reductions for patients with low literacy (adjusted difference -
1.4%, P < 0.001) and allowed for more subjects to obtain an A1c 
of ≤ 7% (odds ratio 4.6, P = 0.02). While this study did not reveal 
changes in endpoints other than A1c and hyperglycemia, other 
trials have shown such a benefit. For instance, Kim et al.21 
showed that diabetes education classes improved self-blood 
glucose monitoring (P = 0.002). This study was not powered to 
detect a result in the secondary endpoints and the study size 
may have been too small to detect a difference. The mean 
adherence rate, 87.7% in interventional arm versus 78.0% in 
usual care arm, respectively, may have been significant if the 
sample size was larger. 
 
Other novel methods created to modify diabetes outcomes in 
patients with low health literacy have been explored. The 
Partnership to Improve Diabetes Education (PRIDE) toolkit 
contains a series of diabetes self-management modules in 
English and Spanish created at a 5th grade reading level.22 The 
toolkit contains diabetes information and shared goal setting 
activities for patients with low health literacy and numeracy.22 
Lay health trainers, the use of peer or lay educators in the 
community, have also been used to improve self-management, 
quality of life, mental health, and illness perception in patients 
with low literacy and poorly controlled diabetes.23 A study by 
Sugita et al.24 used health-literate text messages to improve 
medication adherence for patients with diabetes. While these 
approaches are more complex, all have proved to be effective 
interventions on diabetes self-care and knowledge. 
 
Strengths and Limitations 
The strengths of this study were that it was a randomized, 
controlled trial and that the inclusion criteria was limited to low 
literacy patients including those with lower socioeconomic 
status or education, minorities, and seniors. The primary and 
secondary endpoints assessed validated surrogate markers for 
diabetes and the interventions were simple as well as 
achievable in an ambulatory care clinic setting. Additionally, the 
intervention group spent an average length of 25 minutes in the 
clinic versus the usual care arm of only 20 minutes. Thus, these 
literacy-appropriate interventions could be replicated in a fast-
paced ambulatory care practice setting with minimal time 
restrictions.  
 
Limitations of the pilot study included the small sample size and 
short follow-up time. Due to the small study sample, the  
results were also non-parametric. Numerous health literacy 
assessment instruments are available but the REALM-R was 
chosen for ease in administration and scoring. However, 
limitations of the instrument include that it is a word 
recognition test, not a reading comprehension tool. At baseline, 
while the mean REALM-R values between the two arms did not 
reach statistical significance, slightly higher scores in health 
literacy may predispose patients in the interventional arm to 
have better knowledge on diabetes issues and be more 
comfortable with receiving medication instruction. However, 
since the inclusion criteria focused primarily on low-literacy 
populations, this difference may not have been clinically 
relevant and the interventions used to deal with this 
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population, regardless of REALM-R score, may be universal for 
all. Finally, patients in the usual care arm had a longer duration 
of diabetes since they were older and were on higher total 
doses of insulin at baseline, which may have influenced the 
study results. For example, while these patients may have been 
exposed to a longer period of diabetes education from the time 
of diagnosis, the course of diabetes may be more complicated 
and difficult to treat.  
 
Conclusion 
To improve glycemic control, health literacy levels need to be 
considered when formulating educational strategies to improve 
health outcomes. The teach-back method, personalized action 
plans, and phone follow-ups may lower A1c and reduce 
hyperglycemic events in low health literate patients with 
diabetes. Additional studies with larger sample sizes should be 
done to determine if these methods are effective in patients 
with diabetes along with other chronic care diseases requiring 
self-management. 
 
Practice Implications and Innovations 
The findings from this study suggest that pharmacists can 
improve control of diabetes in those with low health literacy 
and numeracy using simplified teaching methods. The teach-
back method to verify patient understanding, patient-provider 
created action plans to improve self-management, and follow-
up phone calls to reinforce information are all cost-effective 
methods for diabetes education. This combined treatment 
approach may lead to reductions in A1c as well as 
hyperglycemic symptoms. While these interventions were 
performed at a pharmacy-led collaborative practice clinic, the 
methods may be applied to patients with low health literacy in 
all outpatient settings to improve diabetes outcomes. The study 
adds to the evidence that simple methods addressing the 
obstacles of low health literacy may be utilized to improve 
outcomes in patients with diabetes. 
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Table 1. Sample Teach-Back Method and Action Plan 
Sample Teach-Back Method 
 
“We covered a lot today about your diabetes and I want to make sure I explained things clearly. What are the three methods we 
discussed that you have to do to help control your diabetes?” 
 
If the patient cannot remember or accurately repeat what is asked, information is clarified and the patient is asked to teach-back the 
information until they are able to correctly describe medical instruction. 
 
 
Sample Action Plan 
Goal # 1: To keep my sugars between 80 – 130 mg/dL 
Plan: Inject 40 units of Lantus underneath the skin every day at 10 P.M. 
How sure am I that I can do this? 
1 2 3 4 5  6 7 8 9 10 
 
 
 
 
Table 2. Baseline Demographics 
Variablea    Control  Intervention  P-Valueb                  
     (N = 12)  (N = 11) 
Age     63.2 ± 12.7 55.5 ± 14.3  0.19 
Gender 
Male     5 (41.7)  4 (36.4)   0.32 
Female     7 (58.3)  7 (63.6) 
Race 
Black     11 (91.7) 10 (90.9)  NS 
Hispanic     1 (8.3)  1 (9.1) 
Education 
Some high school or less   8 (66.7)  5 (45.5)   
High school graduate or greater  4 (33.3)  5 (45.5)   0.67 
Not reported    0  1 (10.0) 
Annual Income 
< $ 20,000    11 (91.7) 9 (81.8)   
$ 20,000 – 40,000   0  1 (9.1)   NS 
Not reported    1 (8.3)  1 (9.1) 
Diabetes Subtype 
Type 1     1 (8.3)  0   NS 
Type 2     11 (91.7) 11 (100) 
Duration of Diabetes, yrs   19.2 ± 11.9 6.4 ± 6.1   0.01 
REALM-R Score    2 ± 2.5  4.1 ± 2.2   0.06 
DNT-5 Score    1.3 ± 1.8  1.3 ± 1.3   0.97 
A1c, %     9.3 ± 1.7  9.7 ± 1.3   0.47 
 
a Values are expressed as number (%) and means ± standard deviations 
b Not significant, P > 0.05 
Abbreviations: REALM-R = Rapid Estimate of Adult Literacy in Medicine- Revised; DNT-5 = and Diabetic Numeracy Test-5 
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Table 3. Diabetes Regimen and Insulin Dosages 
Parameter    Control  Intervention  P-Valueb,c 
     (N = 12)  (N = 11) 
Baseline      
Diabetes Regimena 
Insulin-Only    4 (33.3)  0   0.95  
Insulin- Orals    6 (50.0)  6 (54.5)   0.83 
Orals-Only    2 (16.7)  4 (36.4)   0.95 
Other     0  1 (9.1)   0.96 
Insulin Dosage, units/kgb 
Basal-Only    0.65 ± 0.41 0.40 ± 0.35  0.14 
Bolus-Only    0.52 ± 0.44 0.06d   NS 
Total (basal and bolus-only)  0.96 ± 0.78 0.41 ± 0.35  0.05 
Study Termination at 3 months 
Diabetes Regimena 
Insulin-Only    5 (41.7)  0   0.04  
Insulin- Orals    6 (50.0)  7 (63.6)   0.51 
Orals-Only    1 (8.3)  3 (27.3)   0.25 
Other     0  1 (9.1)   0.96 
Insulin Dosage, units/kgb 
Basal-Only    0.61 ± 0.36 0.42 ± 0.23  0.20 
Bolus-Only    0.33 ± 0.17 0.25 ± 0.16  NS 
Total (basal and bolus- only)  0.84 ± 0.53 0.48 ± 0.31  0.12 
 
a Values are expressed as number (%) 
b Values are expressed as means ± standard deviation 
c NS = not significant, P > 0.05 
d Standard deviation not provided with N = 1 
 
 
 
Table 4. Effect of Treatment on Primary and Secondary Outcomes at 3 Months 
Variablea    Control  Intervention  P-Valueb 
     (N = 12)  (N = 11) 
End A1c, %    8.2 ± 1.9  7.7 ± 1.1   0.79 
Change in A1c  (Post – Pre, %)  -1.0 ± 2.2 -2.0 ± 1.3  0.02 
Change in A1c (% Reduction)  -9.1 ± 17.8 -20.3 ± 11.9  0.04  
A1c < 7%, no.    2 (9.1)  2 (9.1)   NS 
Blood glucose < 70 mg/dL   0.1 ± 0.3  0   NS 
Blood glucose > 180 mg/dL  1.9 ± 1.6  1.7 ± 1.2   0.97 
Hypoglycemic events/week, no.  0.8 ± 1.0  0.2 ± 0.2   0.08 
Hyperglycemic events/week, no.  2.1 ± 3.8  0.1 ± 0.2   0.04 
Hospitalizations, no.   0.2 ± 0.6  0   NS 
Emergency room visits, no.  0.4 ± 1.2  0.1 ± 0.3   NS 
Testing per day, no.   2.2 ± 1.3  1.5 ± 1.0   0.18 
Medication adherence rate, %  78.0 ± 13.8 87.7 ± 11.7  NS 
 
a Values are expressed as number (%) and means ± standard deviations 
b Not significant, P > 0.05 
 
 
Original Research PRACTICE-BASED RESEARCH 
 
http://z.umn.edu/INNOVATIONS                         2020, Vol. 11, No. 3, Article 1                      INNOVATIONS in pharmacy 
                                                                             DOI: https://doi.org/10.24926/iip.v11i3.2406 
9 
   
 
 
 
Figure 1. Enrollment, randomization, and follow-up 
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Figure 2. Change in HgbA1c for treatment and usual care group for each participant from baseline* 
 
 
 
* P = 0.02 
 
